ERGEA BELFAST LIMITED
Get an alert when ERGEA BELFAST LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£31
-96.1% vs 2024
Net assets
£8.3m
+5.2% highest in 6 filed years
Employees
3
0% vs 2024
Profit before tax
£553k
-17.8% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
6-year trend · vs Health Care median
Accounts
6-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | £3,354,615 | £3,347,922 | £3,256,411 | -2.7% | |
| Operating profit | — | — | — | £452,940 | £671,768 | £565,277 | -15.9% | |
| Profit before tax | — | — | — | £452,940 | £673,278 | £553,332 | -17.8% | |
| Net profit | — | — | — | £346,103 | £504,990 | £412,150 | -18.4% | |
| Cash | — | — | — | — | £798 | £31 | -96.1% | |
| Total assets less current liabilities | — | — | — | £7,389,140 | £7,894,130 | £8,306,280 | +5.2% | |
| Net assets | £5,734,571 | £6,336,349 | £7,043,038 | £7,389,141 | £7,894,130 | £8,306,280 | +5.2% | |
| Equity | £5,734,571 | £6,336,349 | £7,043,038 | £7,389,141 | £7,894,130 | £8,306,280 | +5.2% | |
| Average employees | 3 | 4 | 4 | 4 | 3 | 3 | 0% | |
| Wages | — | — | — | £69,116 | £15,450 | — | — | |
| Directors' remuneration | — | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | 13.5% | 20.1% | 17.4% | |
| Net margin | — | — | — | 10.3% | 15.1% | 12.7% | |
| Return on capital employed | — | — | — | 6.1% | 8.5% | 6.8% | |
| Gearing (liabilities / total assets) | — | — | — | 17.1% | 16.3% | 15.4% | |
| Current ratio | — | — | — | 5.85x | 6.22x | 6.30x | |
| Interest cover | — | — | — | — | — | 47.32x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- ERGEA BELFAST LIMITED 2023-03-01 → present
- MEDIPASS BELFAST LTD. 2013-05-14 → 2023-03-01
- HTI IRELAND LIMITED 2001-05-15 → 2013-05-14
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Sopher + Co LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have conducted a business review and have a reasonable expectation that the Company has adequate resources to continue in operational existence until 31 December 2027, which is more than 12 months from the date of approval of these financial statements. Even in a zero-growth scenario where no new business is added, the Company generates positive cashflows. A material proportion of the business comes from the NHS (backed by UK Government), and from long-term contracts providing certainty of income beyond the Going Concern assessment period. The Directors have assessed the political, economic, social and technology risks and believe the Company is well placed to successfully manage these risks.”
Significant events
- “No adjusting or significant non-adjusting events have occurred between the 31 December reporting date and the date of authorisation.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CORTI, Michele | Director | 2020-11-27 | Dec 1978 | Italian |
| GRAVES, Mark Timothy | Director | 2026-02-19 | Apr 1974 | English |
| MUOLO, John Edward | Director | 2012-11-29 | Jan 1955 | British,American |
| ROLFE, David Anthony | Director | 2025-10-15 | Jul 1972 | British |
| WHEELER, Victor James | Director | 2025-10-15 | Jan 1972 | British |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GILDEN, Ronald | Secretary | 2001-05-15 | 2012-11-29 |
| DAVIES, William Richard | Director | 2003-02-26 | 2012-11-29 |
| ERCIL, Aylin | Director | 2003-02-26 | 2003-09-01 |
| GILDEN, Ronald Wayne | Director | 2001-05-15 | 2012-11-29 |
| REZENDE, Robin | Director | 2013-01-24 | 2025-10-15 |
| REZENDE, Robin | Director | 2003-09-01 | 2012-11-27 |
| ROLFE, David Anthony | Director | 2012-11-29 | 2016-09-24 |
| TOWNSLEY, Michael Colin | Director | 2001-05-15 | 2004-05-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ergea Healthcare Leeds And Belfast Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-10-24 | Active |
| Medipass Healthcare Limited | Corporate entity | Shares 75–100% | 2016-07-01 | Ceased 2016-10-24 |
| Medipass Healthcare Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Ceased 2025-07-10 |
Filing timeline
Last 20 of 107 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-03 | AA | accounts | Accounts with accounts type full | |
| 2026-05-20 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-05-20 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-05-20 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2026-05-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-03-18 | CH01 | officers | Change person director company with change date | |
| 2026-02-20 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-02 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-11-28 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-11-26 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-10-16 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-16 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-16 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-09 | AA | accounts | Accounts with accounts type full | |
| 2025-07-25 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-05-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-23 | AA | accounts | Accounts with accounts type small | |
| 2024-07-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-30 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-06-15 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 14
- Capital events
- 0
- Officers appointed
- 3
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.